US11 and US2 encode gene products expressed early in the replicative cycle of human cytomegalovirus (HCMV), which cause dislocation of human and murine major histocompatibility complex (MHC) class I molecules from the lumen of the endoplasmic reticulum to the cytosol, where the class I heavy chains are rapidly degraded. Human histocompatibility leukocyte antigens (HLA)-C and HLA-G are uniquely resistant to the effects of both US11 and US2 in a human trophoblast cell line as well as in porcine endothelial cells stably transfected with human class I genes. Dislocation and degradation of MHC class I heavy chains do not appear to involve cell type–specific factors, as US11 and US2 are fully active in this xenogeneic model. Importantly, trophoblasts HLA-G and HLA-C possess unique characteristics that allow their escape from HCMV-associated MHC class I degradation. Trophoblast class I molecules could serve not only to block recognition by natural killer cells, but also to guide virus-specific HLA-C– and possibly HLA-G–restricted cytotoxic T-lymphocytes to their targets.
Skip Nav Destination
Article navigation
3 August 1998
Article|
August 03 1998
Trophoblast Class I Major Histocompatibility Complex (MHC) Products Are Resistant to Rapid Degradation Imposed by the Human Cytomegalovirus (HCMV) Gene Products US2 and US11
Danny J. Schust,
Danny J. Schust
From the *Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115; and the ‡Transplantation Biology Research Center, Massachusetts General Hospital, Boston, Massachusetts 02119
Search for other works by this author on:
Domenico Tortorella,
Domenico Tortorella
From the *Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115; and the ‡Transplantation Biology Research Center, Massachusetts General Hospital, Boston, Massachusetts 02119
Search for other works by this author on:
Jörg Seebach,
Jörg Seebach
From the *Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115; and the ‡Transplantation Biology Research Center, Massachusetts General Hospital, Boston, Massachusetts 02119
Search for other works by this author on:
Cindy Phan,
Cindy Phan
From the *Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115; and the ‡Transplantation Biology Research Center, Massachusetts General Hospital, Boston, Massachusetts 02119
Search for other works by this author on:
Hidde L. Ploegh
Hidde L. Ploegh
From the *Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115; and the ‡Transplantation Biology Research Center, Massachusetts General Hospital, Boston, Massachusetts 02119
Search for other works by this author on:
Danny J. Schust
From the *Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115; and the ‡Transplantation Biology Research Center, Massachusetts General Hospital, Boston, Massachusetts 02119
Domenico Tortorella
From the *Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115; and the ‡Transplantation Biology Research Center, Massachusetts General Hospital, Boston, Massachusetts 02119
Jörg Seebach
From the *Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115; and the ‡Transplantation Biology Research Center, Massachusetts General Hospital, Boston, Massachusetts 02119
Cindy Phan
From the *Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115; and the ‡Transplantation Biology Research Center, Massachusetts General Hospital, Boston, Massachusetts 02119
Hidde L. Ploegh
From the *Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115; and the ‡Transplantation Biology Research Center, Massachusetts General Hospital, Boston, Massachusetts 02119
Address correspondence to Hidde L. Ploegh, Ph.D., Department of Pathology, Harvard Medical School, 200 Longwood Ave., Building D2, Rm. 137, Boston, MA 02115. Phone: 617-432-4777; Fax: 617-432-4775; E-mail: [email protected]
Received:
April 10 1998
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1998
J Exp Med (1998) 188 (3): 497–503.
Article history
Received:
April 10 1998
Citation
Danny J. Schust, Domenico Tortorella, Jörg Seebach, Cindy Phan, Hidde L. Ploegh; Trophoblast Class I Major Histocompatibility Complex (MHC) Products Are Resistant to Rapid Degradation Imposed by the Human Cytomegalovirus (HCMV) Gene Products US2 and US11 . J Exp Med 3 August 1998; 188 (3): 497–503. doi: https://doi.org/10.1084/jem.188.3.497
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement